Otirelax ear drops (40mg+10mg)/1g 17.1g №1

Name:
Otirelax. Release formEar drops. INN Lidocaine + phenazone.
Description:
Transparent solution without visible particles. Composition 1 g contains Active substance: phenazone 40 mg, lidocaine hydrochloride 10 mg. Excipients: sodium thiosulfate, ethyl alcohol, purified water, sodium hydroxide (1M solution), glycerin. Pharmacotherapeutic group Other drugs for the treatment of diseases in otology. Analgesics and anesthetics in combination. ATC drug code S02DA30. Pharmacological properties Pharmacodynamics Phenazone (pyrazole derivative) has anti-inflammatory and analgesic effects. Lidocaine (an anesthetic of the amide group) has a local analgesic effect. Pharmacokinetics: The drug does not enter the body with an intact eardrum. Indications for use Local symptomatic treatment of painful conditions of the middle ear, provided that the integrity of the tympanic membrane is preserved: – acute otitis media with congestion; – otitis, as a complication after the flu; – barotraumatic otitis. Contraindications – violation of the integrity of the eardrum; – Hypersensitivity to the components of the drug. Interaction with other medicinal products There is currently no information on interaction with other medicinal products. Precautions It is necessary to ensure the integrity of the eardrum before using the drug. In the case of using the drug with a perforated eardrum, the drug can penetrate into the systemic circulation and lead to complications. After instillation, screw the cap tightly and hide the bottle in the package to protect the drug from light exposure. Information for athletes: the medicinal product contains an active ingredient capable of giving a positive reaction during doping control. Otirelax is indicated for use in children. Pregnancy and lactation There are no data on the safety of using Otirelax during pregnancy or breastfeeding. The drug is not prescribed to pregnant women, except in situations of absolute necessity and only after an assessment of the benefits to the mother and the possible risk to the fetus. Also, there is no data on the transition of the components of the drug into breast milk. It is recommended to avoid the use of this drug in nursing mothers. Influence on the ability to drive vehicles and control mechanisms The drug does not affect the ability to drive a car or work with complex machinery, machines or any other complex equipment that requires increased attention. Dosage and administrationOtirelax is applied topically, by instillation into the external auditory canal 2-3 times a day, 4 drops. To avoid contact of the cold solution with the auricle, the bottle should be warmed in the palms before use. The duration of the use of Otirelax is not more than 10 days, after which the prescribed treatment should be reviewed. Use in childrenOtirelax is indicated for use in children from birth 2-3 times a day, 3-4 drops. Overdose There is no data on overdose when applied topically. Side effect There is a risk of local allergic reactions, irritation and hyperemia of the ear canal. Storage conditions and shelf life Store at a temperature not exceeding 25 ° C in the original packaging. Keep out of the reach of children. Shelf life: 3 years when stored in unopened original packaging. After opening the vial, the drops should be used within 4 weeks. Condition of dispensing from pharmacies Dispensed from pharmacies by prescription. PackagingPlastic dropper bottle 15 ml. Dropper bottle in a carton box with leaflet. Buy Otirelax ear drops (40mg + 10mg) / 1g 17.1g No. 1 Price for Otirelax ear drops (40mg + 10mg) / 1g 17.1g No. 1 one